IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/Fine Chemicals Roundup – September 27

7:10 AM MDT | September 27, 2011 | Deepti Ramesh

FDA ISSUES WARNING LETTER TO API PLANT IN INDIA The U.S. Food and Drug Administration (FDA) issued a warning letter earlier this month to the active pharmaceutical ingredient (API) manufacturing facility of Yag-Mag Labs (Hyderabad, India) located in Gaddapotharam Village, in the state of Andhra Pradesh, India, for deviating from current good manufacturing practice (cGMP). An FDA inspection from June 27, 2011 to July 2, 2011 at the API facility of Yag-Mag Labs identified significant deviations from cGMP for the manufacture of APIs, FDA says. Yag-Mag Labs responded...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa